Awaiting The Part D Shakeout

The Medicare drug benefit has more plans and fewer enrollees than expected. That is a recipe for consolidation, but will the federal government wait for the market to evolve?

By Michael McCaughan

The Bush Administration agrees with critics of the Medicare prescription drug benefit about one thing: the program needs to become...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet